よむ、つかう、まなぶ。
参考資料１ 変異株リスク評価 (7 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00395.html |
| 出典情報 | 新型コロナウイルス感染症対策アドバイザリーボード (第111回 12／21)《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
国立感染症研究所. 感染・伝播性の増加や抗原性の変化が懸念される 新型コロナウイルス（SARS-CoV-2）の変異株について （第 23 報）
Cov-lineages.org. https://cov-lineages.org/index.html
covSPECTRUM. https://cov-spectrum.org/explore/World/AllSamples/Past6M.
ECDC. SARS-CoV-2 variants of concern as of 8 Dec 2022. https://www.ecdc.europa.eu/en/covid19/variants-concern. 2022a.
ECDC. Country overview report: week 47 2022. Produced on 1 Dec 2022.
https://www.ecdc.europa.eu/en/covid-19/country-overviews. 2022b.
GISAID. 2022. https://gisaid.org/.
GitHub. 2022. https://github.com/cov-lineages/pango-designation/issues/1052
Ito, J., Suzuki, R., Uriu, K., Itakura, Y., Zahradnik, J., Deguchi, S., ... & Sato, K. (2022). Convergent
evolution of the SARS-CoV-2 Omicron subvariants leading to the emergence of BQ. 1.1 variant.
bioRxiv. https://www.biorxiv.org/content/10.1101/2022.12.05.519085v1. (preprint).
Jian, F., Yu, Y., Song, W., Yisimayi, A., Yu, L., Gao, Y., Zhang, N., Wang, Y., Shao, F., Hao, X., Xu,
Y., Jin, R., Wang, Y., Xie, X. S., & Cao, Y. (2022). Further humoral immunity evasion of emerging
SARS-CoV-2 BA.4 and BA.5 subvariants. The Lancet. Infectious diseases, 22(11), 1535–1537.
https://doi.org/10.1016/S1473-3099(22)00642-9.
Kurhade, C., Zou, J., Xia, H., Liu, M., Chang, H. C., Ren, P., Xie, X., & Shi, P. Y. (2022). Low
neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by parental mRNA vaccine or
a BA.5-bivalent booster. Nature medicine, 10.1038/s41591-022-02162-x. Advance online
publication. https://doi.org/10.1038/s41591-022-02162-x.
Our World in Data. Coronavirus (COVID-19) cases. As of 7 Dec 2022.
https://ourworldindata.org/covid-cases.
Shen, X., Chalkias, S., Feng, J., Chen, X., Zhou, H., Marshall, J. C., Girard, B., Tomassini, J. E.,
Aunins, A., Das, R., & Montefiori, D. C. (2022). Neutralization of SARS-CoV-2 Omicron BA.2.75
after mRNA-1273 Vaccination. The New England journal of medicine, 387(13), 1234–1236.
https://doi.org/10.1056/NEJMc2210648.
UKHSA. SARS-CoV-2 variants of concern and variants under investigation in England. Technical
briefing 48. 25 Nov 2022.
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data
/file/1120304/technical-briefing-48-25-november-2022-final.pdf.
Wensleers T. Twitter. 2022. https://twitter.com/TWenseleers/status/1580701701178535936
WHO. COVID-19 Weekly Epidemiological Update, Edition 121, published 7 December 2022.
https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---7december-2022. 2022a.
WHO. Tracking SARS-CoV-2 variants. As of 12 Dec 2022. https://www.who.int/activities/trackingSARS-CoV-2-variants. 2022b.
7
Cov-lineages.org. https://cov-lineages.org/index.html
covSPECTRUM. https://cov-spectrum.org/explore/World/AllSamples/Past6M.
ECDC. SARS-CoV-2 variants of concern as of 8 Dec 2022. https://www.ecdc.europa.eu/en/covid19/variants-concern. 2022a.
ECDC. Country overview report: week 47 2022. Produced on 1 Dec 2022.
https://www.ecdc.europa.eu/en/covid-19/country-overviews. 2022b.
GISAID. 2022. https://gisaid.org/.
GitHub. 2022. https://github.com/cov-lineages/pango-designation/issues/1052
Ito, J., Suzuki, R., Uriu, K., Itakura, Y., Zahradnik, J., Deguchi, S., ... & Sato, K. (2022). Convergent
evolution of the SARS-CoV-2 Omicron subvariants leading to the emergence of BQ. 1.1 variant.
bioRxiv. https://www.biorxiv.org/content/10.1101/2022.12.05.519085v1. (preprint).
Jian, F., Yu, Y., Song, W., Yisimayi, A., Yu, L., Gao, Y., Zhang, N., Wang, Y., Shao, F., Hao, X., Xu,
Y., Jin, R., Wang, Y., Xie, X. S., & Cao, Y. (2022). Further humoral immunity evasion of emerging
SARS-CoV-2 BA.4 and BA.5 subvariants. The Lancet. Infectious diseases, 22(11), 1535–1537.
https://doi.org/10.1016/S1473-3099(22)00642-9.
Kurhade, C., Zou, J., Xia, H., Liu, M., Chang, H. C., Ren, P., Xie, X., & Shi, P. Y. (2022). Low
neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by parental mRNA vaccine or
a BA.5-bivalent booster. Nature medicine, 10.1038/s41591-022-02162-x. Advance online
publication. https://doi.org/10.1038/s41591-022-02162-x.
Our World in Data. Coronavirus (COVID-19) cases. As of 7 Dec 2022.
https://ourworldindata.org/covid-cases.
Shen, X., Chalkias, S., Feng, J., Chen, X., Zhou, H., Marshall, J. C., Girard, B., Tomassini, J. E.,
Aunins, A., Das, R., & Montefiori, D. C. (2022). Neutralization of SARS-CoV-2 Omicron BA.2.75
after mRNA-1273 Vaccination. The New England journal of medicine, 387(13), 1234–1236.
https://doi.org/10.1056/NEJMc2210648.
UKHSA. SARS-CoV-2 variants of concern and variants under investigation in England. Technical
briefing 48. 25 Nov 2022.
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data
/file/1120304/technical-briefing-48-25-november-2022-final.pdf.
Wensleers T. Twitter. 2022. https://twitter.com/TWenseleers/status/1580701701178535936
WHO. COVID-19 Weekly Epidemiological Update, Edition 121, published 7 December 2022.
https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---7december-2022. 2022a.
WHO. Tracking SARS-CoV-2 variants. As of 12 Dec 2022. https://www.who.int/activities/trackingSARS-CoV-2-variants. 2022b.
7